Blood pressure and the T174M and M235T polymorphisms of the angiotensinogen gene

Annals of Epidemiology

Volumn 9, Issue 4, 1999, Pages 245-253

  Niu, Tianhua ^a   Chen, Changzhong ^b   Yang, Jianhua ^b   Wang, Binyan ^a   Wang, Zhaoxi ^a   Schork, Nicholas ^a,c   Fang, Zhian ^b   Xu, Xiping ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Anhui MEIZHONG Inst Biomed Sci E   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

Angiotensinogen; Association Studies; Blood Pressure; Genetics; Hypertension

Indexed keywords

ANGIOTENSINOGEN;

ALLELE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHINESE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; HYPERTENSION; POPULATION RESEARCH; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RURAL AREA; SODIUM RETENTION;

ADOLESCENT; ADULT; ALLELES; ANGIOTENSINOGEN; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; REGRESSION ANALYSIS;

EID: 0032928535     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(98)00060-X     Document Type: Article

References (22)

1. Rowland M., Roberts J. Blood pressure levels and hypertension in persons ages 6-74 years. United States, 1976-1980:1982;National Center for Health Statistics, Hyattsville, MD. DHHS Publ. 82-1250.
2. Wu Y.K., Lu C.Q., Gao R.C., Yu J.S., Liu G.C. Nationwide hypertension screening in China during 1979-1980. Chin Med J. (Engl.). 95:1982;101-108.
3. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J.-M., Corvol P. Molecular basis of human hypertension. Role of angiotensinogen Cell. 71:1992;169-180.
4. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., Clark A.J.L. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 330:1994;1629-1633.
5. Caufield M., Lavender P., Newell-Price J., Farrall M., Kamdar S., Daniel H., Lawson M., Freitas P.D., Fogarty P., Clark A.J.L. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 96:1995;687-692.
6. Hata A., Namikawa C., Sasaki M., Sato K., Nakamura T., Tamura K., Lalouel J.-M. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 93:1994;1285-1287.
7. Jeunemaitre X., Inoue I., Williams C., Charru A., Tichet J., Powers M., Sharma A.M., Gimenez-Roqueplo A.-P., Hata A., Corvol P., Lalouel J.-M. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 60:1997;1448-1460.
8. Barley J., Blackwood A., Sagnella G., Markandu N., MacGregor G., Carter N. Angiotensinogen Met235Thr polymorphism in a London normotensive and hypertensive black and white population. J Hum Hypertens. 8:1994;639-640.
9. Hingorani A.D., Sharma P., Jia H., Hopper R., Brown M.J. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension. 28:1996;907-911.
10. Bennett C.L., Schrader A.P., Morris B.J. Cross-sectional analysis of Met235 Thr variant of angiotensinogen gene in severe familial hypertension. Biochem Biophys Res Comm. 197:1993;833-839.
11. Rotimi C., Morrison L., Cooper R., Oyejide C., Effiong E., Ladipo M., Osotemihen B.O., Ward R. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans Hypertension. 24:1994;591-594.
12. Xu X., Niu T., Christiani D.C., Weiss S.T., Zhou Y., Chen C., Yang J., Fang Z., Jiang Z., Liang W., Zhang F. Environmental and occupational determinants of blood pressure in rural communities in China. Ann Epidemiol. 7:1997;95-106.
13. Buffone G.J., Darlington G.J. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem. 31:1985;164-165.
14. Russ A.P., Maerz W., Ruzicka V., Stein U., Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet. 2:1993;609-610.
15. Laird N., Lange N., Stram D. Maximum likelihood computations with repeated measures. Application of the EM algorithm J Am Stat Assoc. 82:1987;97-105.
16. Laird N.M., Ware J.H. Random effects models for longitudinal data. Biometrics. 38:1982;963-974.
17. Hegele R.A., Brunt J.H., Connelly P.W. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation. 90:1994;2207-2212.
18. Ishigami T., Umemura S., Tamura K., Hibi K., Nyui N., Kihara M., Yabana M., Watanabe Y., Sumida Y., Nagahara T., Ochiai H., Ishii M. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension. 30:1997;1325-1330.
19. Sato N., Katsuya T., Rakugi H., Takami S., Nakata Y., Miki T., Higaki J., Ogihara T. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension. 30:1997;321-325.
20. Bigda J., Narkiewicz K., Chrostowska M., Winnicki M., Szczech R., Pawlowski R., Krupa-Wojciechowska B. No effect of genetic variation at the angiotensinogen locus on ambulatory blood pressure level in normotensive subjects. Am J Hypertens. 10:1997;692-695.
21. Cooper R.S., Rotimi C. Hypertension in blacks. Is there a genetic susceptibility? J Hypertens. 12:1994;215-227.
22. Inoue I., Nakajima T., Williams C.S., Quackenbush J., Puryear R., Powers M., Cheng T., Ludwig E.H., Sharma A.M., Hata A., Jeunemaitre X., Lalouel J.-M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 99:1997;1786-1797.